We first developed a China access framework for DTx, outlining value propositions and monetization options for DTx as a whole and its different components on a standalone basis.
Next, we analyzed relevant analog case studies in DTx in China and summarized key takeaways and implications for the client’s product.
We then conferred with payers and potential partners on DTx value perceptions, business opportunities, and monetization strategy and summarized value propositions including better compliance with patients and caregivers, better outcomes in real-world settings, and better socioeconomics for payers.